Skip to main content
Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.970
-0.110 (-2.70%)
Nov 20, 2024, 4:00 PM EST - Market closed

Organogenesis Holdings Revenue

Organogenesis Holdings had revenue of $115.18M in the quarter ending September 30, 2024, with 6.12% growth. This brings the company's revenue in the last twelve months to $455.04M, up 1.34% year-over-year. In the year 2023, Organogenesis Holdings had annual revenue of $433.14M, down -3.94%.

Revenue (ttm)
$455.04M
Revenue Growth
+1.34%
P/S Ratio
1.15
Revenue / Employee
$527,886
Employees
862
Market Cap
526.33M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023433.14M-17.75M-3.94%
Dec 31, 2022450.89M-16.47M-3.52%
Dec 31, 2021467.36M129.06M38.15%
Dec 31, 2020338.30M77.32M29.63%
Dec 31, 2019260.98M67.53M34.91%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2001 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Auna S.A. 1.17B
Fulgent Genetics 277.76M
Talkspace 181.29M
CureVac 70.57M
Opthea 261.86K
Revenue Rankings

ORGO News

More News